ASIA-PACIFIC MEDICAL ENZYMES MARKET FORECAST 2022-2030
The Asia-Pacific medical enzymes market is anticipated to register a CAGR of 7.49% during the estimated period of 2022 to 2030, reaching a revenue share of $1691.85 million by 2030.
ASIA-PACIFIC MEDICAL ENZYMES MARKET FORECAST 2022-2030
Asia-Pacific Medical Enzymes Market by Type (Hydrolase (Hyaluronidase, Lysozymes, Other Hydrolases Enzymes), Thrombolytic (Streptokinase, Urokinase, Other Thrombolytic Enzymes), Digestive Enzyme (Lactase, L-asparaginase, Other Digestive Enzymes), Endonuclease (Benzonase, Other Endonucleases)) Market by Application ( Disease Treatment, Diagnostic Tools, Biomedical Research, Other Applications)
The Asia-Pacific medical enzymes market is anticipated to register a CAGR of 7.49% during the estimated period of 2022 to 2030, reaching a revenue share of $1691.85 million by 2030.
The poor dietary habits in developing countries, increasing weight and eating routine concerns, rapid industrialization, and the rise in research and development expenditure are among the leading factors propelling the regional market’s growth. However, the Asia-Pacific medical enzymes market is likely to be restrained due to raw material availability as well as the associated costs.
To know more about this report, request a free sample copy
The Asia-Pacific medical enzymes market growth assessment entails the evaluation of Indonesia, India, Vietnam, Japan, Thailand, South Korea, China, Australia & New Zealand, and Rest of Asia-Pacific. With the development of advanced technologies, the medical enzymes market in China is expected to grow rapidly. Moreover, due to the rising health awareness, along with the growing per capita income, healthcare expenditure is increasing in the country. Primary healthcare has also gained significant traction in China. In this regard, the nation has introduced numerous policies associated with medical care in order to manage chronic diseases and infections. This was announced under the Healthy China 2030 Plan, initiated for the development of health as well as primary care.
On the other hand, the healthcare system in Japan is considered one of the finest globally, especially in terms of high-quality fundamental care at cost-effective prices. The country spends nearly 10% of its gross domestic product (GDP) on the development of healthcare. Furthermore, with the rise in the geriatric population in Japan, the patient pool of chronic conditions, including cancer, hypertension, and diabetes, also increases. Various other factors like alcohol consumption, smoking, as well as obesity further result in serious diseases, thus propelling the growth of the medical enzymes market in the Asia-Pacific.
The Asia-Pacific medical enzymes market is segmented into type and application. The type category is further segmented into hydrolase, thrombolytic enzyme, digestive enzyme, and endonuclease. Digestive enzymes help break down food while speeding up chemical reactions that turn nutrients into substances that can be absorbed by the digestive tract. The enzymes can also break down proteins, carbohydrates, and lipids. Moreover, their supplementation plays an essential role in managing digestive ailments ranging from pancreatic insufficiency to lactose intolerance and cystic fibrosis.
On the other hand, endonucleases are characterized as enzymes that cleave the phosphodiester bond within a polynucleotide chain. Endonucleases differ from exonucleases, which cleave recognition sequences’ ends rather than the mid-section of the sequences. Restriction enzymes are also endonucleases from eubacteria as well as archaea that recognize a particular DNA sequence. Besides, they also play a crucial part in DNA repair.
Some of the top players operating in the Asia-Pacific medical enzymes market are Advanced Enzyme Technologies, Amano Enzyme, etc.
Advanced Enzyme Technologies, headquartered in Maharashtra, India, is a leading enzyme company that performs the marketing and manufacturing of over 400 products developed from nearly 65 indigenous enzymes and probiotics. The company also has research and development centers across Europe and the United States.
The company’s animal nutrition products are utilized to enhance protein digestibility as well as the bio-availability of amino acids. It also includes degrading powder and liquids for diets comprising barley, corn, wheat, soy, sunflower, and others.
Report Synopsis
| Report Scope | Details |
| Market Forecast Years | 2022-2030 |
| Base Year | 2021 |
| Market Historical Years | 2018-2021 |
| Forecast Units | Revenue ($ Million) |
| Segment Analyzed | Type and Application |
| Countries Analyzed | China, Japan, South Korea, Thailand, Australia & New Zealand, India, Indonesia, Vietnam, and Rest of Asia-Pacific |
| Companies Analyzed |
BASF, DuPont, Roche Holding, Novozymes, DSM, Sanofi, Codexis, Novus, BRAIN, Sekisui, Advanced Enzymes, Amano Enzyme, BBI Solutions, Thermo Fisher Scientific, CPC Biotech |
To request a free sample copy of this report, please complete the form below:
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.
- RESEARCH SCOPE & METHODOLOGY
- STUDY OBJECTIVES
- SCOPE OF STUDY
- METHODOLOGY
- ASSUMPTIONS & LIMITATIONS
- EXECUTIVE SUMMARY
- MARKET SIZE & ESTIMATES
- MARKET OVERVIEW
- MARKET DYNAMICS
- KEY DRIVERS
- INCREASED INVESTMENT IN HEALTHCARE RESEARCH AND FACILITIES
- WIDENING APPLICATION IN MEDICAL INDUSTRY
- GROWING PREVALENCE OF CHRONIC DISEASES AND RISING AGING POPULATION
- KEY RESTRAINTS
- HANDLING AND SAFETY OF ENZYMES
- REGULATIONS FOR MEDICAL ENZYMES
- KEY DRIVERS
- KEY ANALYTICS
- IMPACT OF COVID-19 ON MEDICAL ENZYMES MARKET
- KEY MARKET TRENDS
- PORTER’S FIVE FORCES ANALYSIS
- BUYERS POWER
- SUPPLIERS POWER
- SUBSTITUTION
- NEW ENTRANTS
- INDUSTRY RIVALRY
- OPPORTUNITY MATRIX
- VENDOR LANDSCAPE
- VALUE CHAIN ANALYSIS
- RESEARCH AND DEVELOPMENT
- OPERATIONS
- OUTBOUND LOGISTICS
- KEY BUYING CRITERIA
- COST
- QUALITY
- APPLICATION
- REGULATORY FRAMEWORK
- MARKET BY TYPE
- HYDROLASE
- HYALURONIDASE
- LYSOZYMES
- OTHER HYDROLASES ENZYMES
- THROMBOLYTIC
- STREPTOKINASE
- UROKINASE
- OTHER THROMBOLYTIC ENZYMES
- DIGESTIVE ENZYME
- LACTASE
- L-ASPARAGINASE
- OTHER DIGESTIVE ENZYMES
- ENDONUCLEASE
- BENZONASE
- OTHER ENDONUCLEASES
- HYDROLASE
- MARKET BY APPLICATION
- DISEASE TREATMENT
- DIAGNOSTIC TOOLS
- BIOMEDICAL RESEARCH
- OTHER APPLICATIONS
- GEOGRAPHICAL ANALYSIS
- ASIA-PACIFIC
- MARKET SIZE & ESTIMATES
- KEY GROWTH ENABLERS
- KEY CHALLENGES
- KEY PLAYERS
- COUNTRY ANALYSIS
- CHINA
- JAPAN
- INDIA
- SOUTH KOREA
- INDONESIA
- THAILAND
- VIETNAM
- AUSTRALIA & NEW ZEALAND
- REST OF ASIA-PACIFIC
- ASIA-PACIFIC
- COMPETITIVE LANDSCAPE
- KEY STRATEGIC DEVELOPMENTS
- MERGERS & ACQUISITIONS
- PRODUCT LAUNCHES & DEVELOPMENTS
- PARTNERSHIPS & AGREEMENTS
- BUSINESS EXPANSIONS & DIVESTITURES
- COMPANY PROFILES
- ADVANCED ENZYMES
- AMANO ENZYME
- BASF
- BBI SOLUTIONS
- BRAIN
- CODEXIS
- CPC BIOTECH
- DSM
- DUPONT
- NOVOZYMES
- NOVUS
- ROCHE
- SANOFI
- SEKISUI
- THERMO FISHER SCIENTIFIC
- KEY STRATEGIC DEVELOPMENTS
LIST OF TABLES
TABLE 1: MARKET SNAPSHOT – MEDICAL ENZYMES
TABLE 2: MEDICAL APPLICATION OF VARIOUS ENZYMES
TABLE 3: APPLICATIONS OF ENZYMES IN PHARMACEUTICALS INDUSTRY
TABLE 4: REGULATORY FRAMEWORK
TABLE 5: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 6: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 7: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY HYDROLASE ENZYME, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 8: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY HYDROLASE ENZYME, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 9: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY THROMBOLYTIC, ENZYME HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 10: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY THROMBOLYTIC ENZYME, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 11: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 12: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 13: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY ENDONUCLEASE ENZYME, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 14: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY ENDONUCLEASE ENZYME, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 15: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 16: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY APPLICATION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 17: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 18: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 19: LEADING PLAYERS OPERATING IN ASIA-PACIFIC MEDICAL ENZYMES MARKET
TABLE 20: LIST OF MERGERS & ACQUISITIONS
TABLE 21: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 22: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 23: LIST OF BUSINESS EXPANSIONS & DIVESTITURE
LIST OF FIGURES
FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER’S FIVE FORCES ANALYSIS
FIGURE 3: OPPORTUNITY MATRIX
FIGURE 4: VENDOR LANDSCAPE
FIGURE 5: VALUE CHAIN ANALYSIS
FIGURE 6: KEY BUYING CRITERIA
FIGURE 7: ASIA-PACIFIC MEDICAL ENZYMES MARKET, GROWTH POTENTIAL, BY TYPE, IN 2021
FIGURE 8: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY HYDROLASE, 2022-2030 (IN $ MILLION)
FIGURE 9: ASIA-PACIFIC MEDICAL ENZYMES MARKET, GROWTH POTENTIAL, BY HYDROLASE ENZYME, IN 2021
FIGURE 10: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY HYALURONIDASE, 2022-2030 (IN $ MILLION)
FIGURE 11: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY LYSOZYMES, 2022-2030 (IN $ MILLION)
FIGURE 12: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY OTHER HYDROLASES ENZYMES, 2022-2030 (IN $ MILLION)
FIGURE 13: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY THROMBOLYTIC ENZYMES, 2022-2030 (IN $ MILLION)
FIGURE 14: ASIA-PACIFIC MEDICAL ENZYMES MARKET, GROWTH POTENTIAL, BY THROMBOLYTIC ENZYME, IN 2021
FIGURE 15: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY STREPTOKINASE, 2022-2030 (IN $ MILLION)
FIGURE 16: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY UROKINASE, 2022-2030 (IN $ MILLION)
FIGURE 17: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY OTHER THROMBOLYTIC ENZYMES, 2022-2030 (IN $ MILLION)
FIGURE 18: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME, 2022-2030 (IN $ MILLION)
FIGURE 19: ASIA-PACIFIC MEDICAL ENZYMES MARKET, GROWTH POTENTIAL, BY DIGESTIVE ENZYME, IN 2021
FIGURE 20: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY LACTASE, 2022-2030 (IN $ MILLION)
FIGURE 21: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY L-ASPARAGINASE, 2022-2030 (IN $ MILLION)
FIGURE 22: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY OTHER DIGESTIVE ENZYMES, 2022-2030 (IN $ MILLION)
FIGURE 23: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY ENDONUCLEASE, 2022-2030 (IN $ MILLION)
FIGURE 24: ASIA-PACIFIC MEDICAL ENZYMES MARKET, GROWTH POTENTIAL, BY ENDONUCLEASE, IN 2021
FIGURE 25: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY BENZONASE, 2022-2030 (IN $ MILLION)
FIGURE 26: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY OTHER ENDONUCLEASES, 2022-2030 (IN $ MILLION)
FIGURE 27: ASIA-PACIFIC MEDICAL ENZYMES MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2021
FIGURE 28: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY DISEASE TREATMENT, 2022-2030 (IN $ MILLION)
FIGURE 29: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY DIAGNOSTIC TOOLS, 2022-2030 (IN $ MILLION)
FIGURE 30: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY BIOMEDICAL RESEARCH, 2022-2030 (IN $ MILLION)
FIGURE 31: ASIA-PACIFIC MEDICAL ENZYMES MARKET, BY OTHER APPLICATIONS, 2022-2030 (IN $ MILLION)
FIGURE 32: ASIA-PACIFIC MEDICAL ENZYMES MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
FIGURE 33: CHINA MEDICAL ENZYMES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 34: JAPAN MEDICAL ENZYMES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 35: INDIA MEDICAL ENZYMES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 36: SOUTH KOREA MEDICAL ENZYMES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 37: INDONESIA MEDICAL ENZYMES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 38: THAILAND MEDICAL ENZYMES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 39: VIETNAM MEDICAL ENZYMES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 40: AUSTRALIA & NEW ZEALAND MEDICAL ENZYMES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 41: REST OF ASIA-PACIFIC MEDICAL ENZYMES MARKET, 2022-2030 (IN $ MILLION)
- GEOGRAPHICAL ANALYSIS
- ASIA-PACIFIC
- MARKET SIZE & ESTIMATES
- KEY GROWTH ENABLERS
- KEY CHALLENGES
- KEY PLAYERS
- COUNTRY ANALYSIS
- CHINA
- JAPAN
- INDIA
- SOUTH KOREA
- INDONESIA
- THAILAND
- VIETNAM
- AUSTRALIA & NEW ZEALAND
- REST OF ASIA-PACIFIC
- ASIA-PACIFIC
- MARKET BY TYPE
- HYDROLASE
- HYALURONIDASE
- LYSOZYMES
- OTHER HYDROLASES ENZYMES
- THROMBOLYTIC
- STREPTOKINASE
- UROKINASE
- OTHER THROMBOLYTIC ENZYMES
- DIGESTIVE ENZYME
- LACTASE
- L-ASPARAGINASE
- OTHER DIGESTIVE ENZYMES
- ENDONUCLEASE
- BENZONASE
- OTHER ENDONUCLEASES
- HYDROLASE
- MARKET BY APPLICATION
- DISEASE TREATMENT
- DIAGNOSTIC TOOLS
- BIOMEDICAL RESEARCH
- OTHER APPLICATIONS
To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.